Psilera
Welcome to the era of mindful medicine.
Tampa, United States · Founded 2019 · $48.1M raised
- Headquarters
- Tampa, Florida
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- psilera.com
- Total Funding
- $48.1M
- Last Round
- $8.8M Extension RoundMay 2026
- Rounds
- 6
About
Psilera is a clinical-stage biotechnology company pioneering novel therapies for hard-to-treat neurological disorders through next-generation precision neuroscience. The company has created six serotonergic compound families covering over 1 million novel compounds, with two issued USPTO patents.
Summary
Psilera is a Biotech company based in Tampa, United States, founded in 2019. It has raised $48.1M in total across 6 rounds, most recently a $8.8M Extension Round round in May 2026. Investors include National Institutes of Health.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2026
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...